Breakthrough study shows benefits of diagnosing hidden respiratory diseases

FHS
May 20, 2024
5:26 pm

Finding and treating people with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) improved their health and reduced their healthcare visits for respiratory symptoms in the year after diagnosis, according to a world-first clinical trial published in the New England Journal of Medicine.

Pfizer plans another $500M in cost cuts, expects $3.1B in revenue from Seagen in 2024

Pfizer’s not-so-good year continues. The New York pharma giant’s shares $PFE slid 7% before Wednesday’s opening bell after Pfizer said it plans to cut another

December 14, 2023

New study investigates the relationship between PTSD, diet, and the gut microbiome

The human gut microbiome has a significant impact on our health. Research has shown that it can influence the development and response of emotions, but

October 20, 2023

Pharmalittle: FDA approves BioMarin gene therapy for hemophilia A; former Pfizer worker charged with insider trading

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal

June 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.